|AI Robots Name||P/L|
|AI Robots Name||P/L|
CRON moved above its 50-day moving average on November 18, 2022 date and that indicates a change from a downward trend to an upward trend. In 40 of 49 similar past instances, the stock price increased further within the following month. The odds of a continued upward trend are 82%.
The Momentum Indicator moved above the 0 level on November 29, 2022. You may want to consider a long position or call options on CRON as a result. In of 111 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .
The Moving Average Convergence Divergence (MACD) for CRON just turned positive on November 18, 2022. Looking at past instances where CRON's MACD turned positive, the stock continued to rise in of 48 cases over the following month. The odds of a continued upward trend are .
The 10-day moving average for CRON crossed bullishly above the 50-day moving average on November 22, 2022. This indicates that the trend has shifted higher and could be considered a buy signal. In of 13 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .
Following a +1 3-day Advance, the price is estimated to grow further. Considering data from situations where CRON advanced for three days, in of 232 cases, the price rose further within the following month. The odds of a continued upward trend are .
The RSI Indicator demonstrated that the stock has entered the overbought zone. This may point to a price pull-back soon.
The Stochastic Oscillator entered the overbought zone. Expect a price pull-back in the foreseeable future.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where CRON declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
CRON broke above its upper Bollinger Band on December 01, 2022. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. CRON’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.097) is normal, around the industry mean (5.923). P/E Ratio (0.000) is within average values for comparable stocks, (48.008). CRON's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (1.500). CRON has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.024). P/S Ratio (13.717) is also within normal values, averaging (115.015).
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. CRON’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 93, placing this stock better than average.
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
pharmaceutical, medical marijuana, cannabis
A.I.dvisor indicates that over the last year, CRON has been closely correlated with OGI. These tickers have moved in lockstep 82% of the time. This A.I.-generated data suggests there is a high statistical probability that if CRON jumps, then OGI could also see price increases.
|OGI - CRON|
|TLRY - CRON|
|CGC - CRON|
|ACB - CRON|
|SNDL - CRON|